Showing results (491-500 of 579) with videos related to
Sort By:
Pageof 58
Infection and Immunity|April 5, 2017
Clumping Factor B Promotes Adherence of Staphylococcus aureus to Corneocytes in Atopic DermatitisOrla M Fleury, Maeve A McAleer, Cécile Feuillie, et al.Dermatology and Therapy|February 14, 2025
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of EfficacyJonathan I Silverberg, Thomas Bieber, Amy S Paller, et al.Investigative Ophthalmology & Visual Science|May 8, 2014
siRNA silencing of the mutant keratin 12 allele in corneal limbal epithelial cells grown from patients with Meesmann's epithelial corneal dystrophyDavid G Courtney, Sarah D Atkinson, Edwin H A Allen, et al.European Journal of Medical Genetics|April 29, 2022
The VASCERN-VASCA working group diagnostic and management pathways for severe and/or rare infantile hemangiomasAndrea Diociaiuti, Eulalia Baselga, Laurence M Boon, et al.Journal of the American Academy of Dermatology|July 7, 2026
Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension studyAlan D Irvine, Amy S Paller, Elaine C Siegfried, et al.Oncogene|November 9, 2010
Absence of the Birt-Hogg-Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibilityR S Preston, A Philp, T Claessens, et al.Scientific Reports|February 15, 2020
Full annual monitoring of Subantarctic Emiliania huxleyi populations reveals highly calcified morphotypes in high-CO2 winter conditionsA S Rigual-Hernández, T W Trull, J A Flores, et al.The Journal of Allergy and Clinical Immunology|February 11, 2012
Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiencySanja Kezic, Gráinne M O'Regan, René Lutter, et al.European Journal of Medical Genetics|October 12, 2022
The VASCERN-VASCA working group diagnostic and management pathways for lymphatic malformationsNader Ghaffarpour, Eulalia Baselga, Laurence M Boon, et al.The British Journal of Dermatology|January 23, 2025
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)Jonathan I Silverberg, Lawrence F Eichenfield, Andrew Blauvelt, et al.Pageof 58